What Is DHEA-S (Male)? Normal vs Optimal Range Explained

The lab range of 80–560 µg/dL spans a sevenfold range—from an 80-year-old man with minimal adrenal output to a 25-year-old at peak production. A 40-year-old man with DHEA-S of 120 µg/dL technically falls within "normal" but is functioning at adrenal levels typical of someone 30 years older. The CTD maps over 1,400 compound interactions with DHEA metabolism genes, highlighting the hormone's role as a master precursor that feeds into testosterone, estrogen, and numerous neurosteroid pathways. In men, approximately 5–10 percent of circulating testosterone derives from peripheral conversion of adrenal DHEA-S—a contribution that becomes proportionally more important as testicular testosterone production declines with age. The optimal 250–450 µg/dL range represents robust adrenal reserve with adequate precursor supply. Unlike cortisol, DHEA-S does not follow a circadian rhythm—its sulfated form has a half-life of 7–10 hours, providing a stable measurement that can be drawn at any time of day without timing constraints.

PubMed indexes over 11,000 clinical publications on DHEA-S, with aging research constituting a major focus. The progressive decline of DHEA-S—termed "adrenopause"—parallels the testosterone decline of andropause but follows its own trajectory. Large cohort analyses consistently associate low DHEA-S in men with increased cardiovascular mortality, reduced bone mineral density, insulin resistance, and depressive symptoms, independent of testosterone levels. The cortisol-to-DHEA-S ratio has emerged as a more informative stress marker than either hormone alone: chronic psychological or physical stress shunts the shared precursor pregnenolone toward cortisol production at the expense of DHEA-S, producing a rising ratio that predicts immune dysfunction and accelerated biological aging. Men in high-stress occupations—military personnel, first responders, and healthcare shift workers—consistently demonstrate elevated cortisol-to-DHEA-S ratios in occupational health assessments, confirming this pattern across diverse populations.

Very high DHEA-S in men—above 600–700 µg/dL in an adult male—is uncommon and warrants consideration of adrenal pathology including congenital adrenal hyperplasia (21-hydroxylase deficiency) and adrenal tumors. DHEA supplementation (25–100 mg daily) has been studied in aging men with mixed results: some trials show modest improvements in body composition, bone density, and well-being, while others show no significant benefit. The most consistent finding is that DHEA supplementation benefits those who are genuinely deficient (DHEA-S below 150 µg/dL) but provides minimal additional value in men with already-adequate levels. Monitoring both DHEA-S and estradiol during supplementation is important because excess DHEA can aromatize to estrogen via peripheral aromatase activity, potentially causing gynecomastia. Prostate-specific antigen (PSA) should also be tracked as a safety precaution in men over 40.